We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Inherited Epilepsy Due to Defective Sodium Channels

By Biotechdaily staff writers
Posted on 25 Jun 2002
Researchers investigating the molecular basis for epilepsy have found that mutant sodium channels are a likely cause. More...
The research was reported in the June 13, 2002, issue of Neuron.

Inherited epilepsy syndromes account for about 5% of all epilepsies. Many of the identified genetic mutations associated with inherited epilepsies are in genes that encode ion channels that regulate the flow of electric current, in the form of charged molecules, into or out of the cell.

The current study focused on three sodium channel mutations that are associated with a syndrome called generalized epilepsy with febrile seizures plus (GEFS+). Researchers from Vanderbilt University Medical Center (Nashville, TN, USA) isolated the human SCN1A sodium channel gene from individuals with this type of epilepsy and introduced the gene, with or without epilepsy-associated mutations, into normal human cells in the laboratory.

"We were able to reconstitute sodium channel function in the laboratory in a way that is very similar to the natural neuronal cell in a human being,” explained Dr. Alfred L. George.

With this system, the investigators examined sodium channels bearing one of three epilepsy-associated mutations. In each case, they found that the functional properties of the mutant channels were very similar to those of a normal channel, but that the mutant sodium channels failed to become completely inactivated. Complete inactivation protects the cell from repetitive electrical discharge by closing the ion channel.

"In the case of the mutant sodium channels, the inactivation process is defective.” Dr. George said. "What this does, is allow sodium to continue to enter the cell, leading to a state of hyperexcitability that makes repetitive firing--a hallmark of seizure activity--more likely. This minor defect is sufficient to render the cell susceptible to repeat firing. It is a plausible mechanism for epilepsy at the cellular and molecular level.”

Now that the physiologic event has been identified, drugs can be designed and tested to find those best at suppressing the abnormal non-inactivating current while leaving the normal current alone.



Related Links:
Vanderbilt University Medical Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.